Abstract
To analyze clinical characteristics and outcome of COVID-19 patients with underlying rheumatic diseases (RD) on immunosuppressive agents. A case series of COVID-19 patients with RD on disease modifying anti-rheumatic drugs (DMARDs) were studied by a retrospective chart review. A literature search identified 9 similar studies of single cases and case series, which were also included. There were 4 COVID-19 inpatients with RD from our hospital, and the mean age was 57 ± 21 years. Two patients had a mild infection, and 2 developed severe COVID-19 related respiratory complications, including 1 patient on secukinumab requiring mechanical ventilation and 1 patient on rituximab developing viral pneumonia requiring supplemental oxygenation. All 4 patients had elevated acute phase reactants, 2 patients had mild COVID-19 with lymphopenia, and 2 patients had severe COVID-19 with normal lymphocyte counts, and high levels of IL-6. None of the patients exhibited an exacerbation of their underlying RD. In the literature, there were 9 studies of COVID-19 involving 197 cases of various inflammatory RD. Most patients were on DMARDs or biologics, of which TNFα inhibitors were most frequently used. Two tocilizumab users had a mild infection. Two pa...Continue Reading
Citations
Aug 21, 2020·Annals of the Rheumatic Diseases·Pierre-Marie DuretLaurent Messer
Jun 28, 2020·Rheumatology International·Ilke Coskun BenlidayiRengin Guzel
Jul 28, 2020·Annals of the Rheumatic Diseases·Xiao-Huan ChenJames Cheng Chung Wei
Jan 4, 2021·Rheumatology International·Sakir AhmedOlena Zimba
Jan 10, 2021·Clinical Rheumatology·Timothy ArleoArezou Khosroshahi
Jan 30, 2021·Current Rheumatology Reports·Aikaterini Thanou, Amr H Sawalha
Dec 24, 2020·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Elena BeyzarovPatrick Caubel
Feb 18, 2021·Cell Reports·Romain GasserAndrés Finzi
Feb 21, 2021·Autoimmunity Reviews·Chuanhui XuRong Mu
Oct 15, 2020·Dermatologic Therapy·Amir Mohammad BeyzaeeMohamad Goldust
Sep 7, 2020·Journal of the American Academy of Dermatology·Joel M GelfandChristopher T Ritchlin
May 12, 2021·Fundamental & Clinical Pharmacology·Amandine DernoncourtBenjamin Batteux
May 28, 2021·Journal of Medical Virology·Elliot H Akama-Garren, Jonathan X Li
Jul 1, 2021·Clinical Rheumatology·Rocío-V Gamboa-CárdenasManuel Ugarte-Gil
Jun 29, 2021·Frontiers in Immunology·Augusta OrtolanRoberta Ramonda
Sep 15, 2021·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Sudarsan KrishnasamyArvind Bagga
Sep 28, 2021·Lupus·Rajalingham SakthiswaryNoor Azman Muhammad Aizat
Dec 5, 2021·RMD Open·Cathy Mireille Melong Pianta TalengAxel Finckh